Scarica l'app Stockscreener
513.03
1.44%
7.28
Dopo l'orario di chiusura:
511.50
-1.53
-0.30%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$505.75
Aprire:
$509.73
Volume 24 ore:
4.56M
Relative Volume:
2.03
Capitalizzazione di mercato:
$190.65B
Reddito:
$45.20B
Utile/perdita netta:
$6.87B
Rapporto P/E:
28.21
EPS:
18.1888
Flusso di cassa netto:
$6.75B
1 W Prestazione:
+10.42%
1M Prestazione:
+14.47%
6M Prestazione:
-11.66%
1 anno Prestazione:
+24.49%
Intervallo 1D:
$499.56
$514.80
Intervallo di 1 settimana:
$458.91
$515.96
Portata 52W:
$401.45
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, NTRA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | DZ Bank | Buy |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MarketWatch
Laboratory Information Management Systems (LIMS) Market Size Expected to Reach USD 5.19 Billion by 2030 | MarketsandMarkets™ - GlobeNewswire Inc.
Thermo Fisher (TMO) Coverage Resumed with Market Perform Rating and $520 Target - GuruFocus
Bernstein SocGen resumes Thermo Fisher stock coverage with market perform - Investing.com Canada
Thermo Fisher Scientific (TMO) Stock After Recent Volatility Is The Current Price Reasonable - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Is Thermo Fisher (TMO) Quietly Redefining Its Edge With AI-Enabled, End-to-End Biopharma Tools? - Yahoo Finance Singapore
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.23% on Jun 25: Key Drivers Unveiled - TradingKey
Q1 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Thermo Fisher gains as investors weigh growth targets, Clario integration, and fresh analyst support - Quiver Quantitative
Thermo Fisher Scientific’s Dr Anil Kane Discusses How AI and Strategic Partnerships Are Reshaping Contract Drug Development at BIO 2026 - BioPharm International
TMO Forecast — Price Target — Prediction for 2027 - TradingView
Thermo Fisher Scientific (TMO) Showcases AI Tools As Fair Value Narrative Stays In Focus - Sahm
Thermo Fisher Scientific Inc (TMO) Stock Up 4.9% and Still Under - GuruFocus
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher Is Down 27% From Its Highs. The EPS Trough Looks Like It Is Already Behind the Company - TIKR.com
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.84% on Jun 24: What Investors Need To Know - TradingKey
Thermo Fisher (NYSE:TMO) Draws Attention With Expanding AI Strategy - Kalkine Media
Is Thermo Fisher Scientific Inc. (TMO) a Top Life Sciences Tools Stock After New Analyst Coverage? - Insider Monkey
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MarketWatch
Can Unread Emails Trigger Arbitration? 9th Circ. Airs Doubts - Law360
Thermo Fisher Scientific Showcases New Capabilities Across Manufacturing, Clinical Development and AI-Enabled Research at BIO International 2026 - BioSpace
Thermo Fisher (TMO) to Highlight Innovations at BIO Internationa - GuruFocus
Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a 28.97% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Thermo Fisher Scientific launches PPD CorEvitas Chronic Hand Eczema Registry - Select Science
Thermo Fisher Scientific’s latest mass spec innovations: new Orbitrap, AI capabilities, and complete workflows - Select Science
Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market - MarketWatch
Shapiro Administration Highlights the Need for Funding to Grow Pennsylvania’s Innovation Economy During Visit to Thermo Fisher Scientific in Dauphin County - PA Department of Community & Economic Development (.gov)
Piper Sandler Initiates Coverage of Thermo Fisher Scientific (TMO) with a Neutral View - Yahoo Finance
Thermo Fisher Scientific, Inc.: - marketscreener.com
Is Thermo Fisher Scientific stock underperforming the S&P 500? - MSN
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Thermo Fisher Tests SpheriCal Calibration As Potential Edge In Mass Spectrometry - Yahoo Finance
Xponance LLC Buys 4,436 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Swiss National Bank - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stake Cut by Polen Capital Management LLC - MarketBeat
ICICI Prudential Asset Management Co Ltd Trims Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
UniSuper Management Pty Ltd Sells 5,100 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Purchased by Nuveen LLC - MarketBeat
Thermo Fisher Scientific (NYSE:TMO) Upgraded by Piper Sandler to "Hold" Rating - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Aviva PLC - MarketBeat
Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch
Thermo Fisher Scientific Introduces the Gibco CTS Compleo Fill and Finish System - Medical Product Outsourcing
Piper Sandler Initiates Thermo Fisher Scientific(TMO.US) With Hold Rating, Announces Target Price $510 - Moomoo
This Daktronics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Piper Sandler initiates Thermo Fisher stock coverage at neutral By Investing.com - Investing.com Australia
Piper Sandler initiates Thermo Fisher stock coverage at neutral - Investing.com
Metis Global Partners LLC Sells 3,963 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Piper Sandler Initiates Thermo Fisher Scientific at Neutral With $510 Price Target - Moomoo
Thermo Fisher Scientific Inc. $TMO Shares Sold by GW&K Investment Management LLC - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.54%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):